$
7.560
-0.09(-1.176%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
7.730
Open
7.730
VWAP
--
Vol
693.34K
Mkt Cap
379.04M
Low
7.495
Amount
--
EV/EBITDA(TTM)
--
Total Shares
49.26M
EV
376.70M
EV/OCF(TTM)
--
P/S(TTM)
1.63
Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
41.74M
-27.52%
-0.220
-27.72%
42.08M
-25.74%
-0.212
+0.4%
44.52M
-25.22%
-0.188
-55.95%
Estimates Revision
The market is revising Downward the revenue expectations for Cryoport, Inc. (CYRX) for FY2025, with the revenue forecasts being adjusted by -4.47% over the past three months. During the same period, the stock price has changed by 35.48%.
Revenue Estimates for FY2025
Revise Downward
down Image
-4.47%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+2.56%
In Past 3 Month
Stock Price
Go Up
up Image
+35.48%
In Past 3 Month
5 Analyst Rating
up Image
40.21% Upside
Wall Street analysts forecast CYRX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CYRX is 10.60 USD with a low forecast of 7.00 USD and a high forecast of 15.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
2 Hold
0 Sell
Moderate Buy
up Image
40.21% Upside
Current: 7.560
sliders
Low
7.00
Averages
10.60
High
15.00
Stephens
NULL
to
Overweight
initiated
$13
2025-07-21
Reason
Stephens resumed coverage of Cryoport with an Overweight rating and $13 price target. The firm says the company has a large platform of supply chain solutions for the growing cell and gene therapy industry. Cryoport will benefit as the macro environment normalizes and therapies move through the clinical pipeline, the analyst tells investors in a research note.
BTIG
Buy
downgrade
$13 -> $10
2025-07-07
Reason
BTIG lowered the firm's price target on Cryoport to $10 from $13 and keeps a Buy rating on the shares following the firm's survey of biopharma manufacturers. R&D Services budgets will likely face the most risk and headwinds over the next 2 years, the analyst tells investors in a research note.
Guggenheim
Subbu Nambi
Strong Buy
Reiterates
$10
2025-04-16
Reason
Needham
David Saxon
Strong Buy
Reiterates
$11
2025-04-16
Reason
Needham
David Saxon
Strong Buy
Reiterates
$11
2025-04-10
Reason
Needham
David Saxon
Strong Buy
Reiterates
$11
2025-04-01
Reason

Valuation Metrics

The current forward P/E ratio for Cryoport Inc (CYRX.O) is -9.91, compared to its 5-year average forward P/E of -66.72. For a more detailed relative valuation and DCF analysis to assess Cryoport Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-66.72
Current PE
-9.91
Overvalued PE
190.99
Undervalued PE
-324.43

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
10.84
Current EV/EBITDA
117.71
Overvalued EV/EBITDA
133.45
Undervalued EV/EBITDA
-111.76

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
5.79
Current PS
2.28
Overvalued PS
9.83
Undervalued PS
1.74

Financials

Annual
Quarterly
FY2025Q1
YoY :
+10.05%
41.04M
Total Revenue
FY2025Q1
YoY :
-45.83%
-9.48M
Operating Profit
FY2025Q1
YoY :
-39.95%
-9.03M
Net Income after Tax
FY2025Q1
YoY :
-34.88%
-0.28
EPS - Diluted
FY2025Q1
YoY :
+4.83%
-8.42M
Free Cash Flow
FY2025Q1
YoY :
+12.43%
45.42
Gross Profit Margin - %
FY2025Q1
YoY :
-26.54%
-16.36
FCF Margin - %
FY2025Q1
YoY :
-45.44%
-22.00
Net Margin - %

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
3.3M
USD
12
3-6
Months
131.5K
USD
10
6-9
Months
1.6M
USD
7
0-12
Months
26.9K
USD
3
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
55.0K
Volume
Months
6-9
1
609.0K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

CYRX News & Events

Events Timeline

2025-05-07 (ET)
2025-05-07
16:08:55
Cryoport reports Q1 EPS (28c), consensus (26c)
select
2025-03-31 (ET)
2025-03-31
09:09:36
DHL Group acquires Cryopdp from Cryoport, terms not disclosed
select
2025-03-04 (ET)
2025-03-04
16:14:31
Cryoport reports Q4 EPS (42c), consensus (31c)
select
Sign Up For More Events

News

3.0
07-29NASDAQ.COM
CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Should You Buy?
4.0
07-22Benzinga
Assessing CryoPort: Insights From 4 Financial Analysts
9.5
07-22PRnewswire
Cryoport to Report Second Quarter 2025 Financial Results on August 5, 2025
Sign Up For More News

FAQ

arrow icon

What is Cryoport Inc (CYRX) stock price today?

The current price of CYRX is 7.56 USD — it has decreased -1.18 % in the last trading day.

arrow icon

What is Cryoport Inc (CYRX)'s business?

arrow icon

What is the price predicton of CYRX Stock?

arrow icon

What is Cryoport Inc (CYRX)'s revenue for the last quarter?

arrow icon

What is Cryoport Inc (CYRX)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Cryoport Inc (CYRX)'s fundamentals?

arrow icon

How many employees does Cryoport Inc (CYRX). have?

arrow icon

What is Cryoport Inc (CYRX) market cap?